UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

RASSF1A, puppeteer of cellular homeostasis, fights tumorigenesis, and metastasis-an updated review

Cell death & disease, 2019-12, Vol.10 (12), p.928-13, Article 928

2019

Volltextzugriff (PDF)

RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non-Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway

Cancer research (Chicago, Ill.), 2016-03, Vol.76 (6), p.1627-1640

2016

Volltextzugriff (PDF)

Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review)

International journal of oncology, 2024-07, Vol.65 (1), Article 68

2024

Volltextzugriff (PDF)

Optimization of Advanced Live-Cell Imaging through Red/Near-Infrared Dye Labeling and Fluorescence Lifetime-Based Strategies

International journal of molecular sciences, 2021-10, Vol.22 (20), p.11092

2021

Volltextzugriff (PDF)

Centrosome, the Newly Identified Passenger through Tunneling Nanotubes, Increases Binucleation and Proliferation Marker in Receiving Cells

International journal of molecular sciences, 2021-09, Vol.22 (18), p.9680

2021

Volltextzugriff (PDF)

Hypoxia-induced activation of NDR2 underlies brain metastases from Non-Small Cell Lung Cancer

Cell death & disease, 2023-12, Vol.14 (12), p.823-823, Article 823

2023

Volltextzugriff (PDF)

The Use of Pro-Angiogenic and/or Pro-Hypoxic miRNAs as Tools to Monitor Patients with Diffuse Gliomas

International journal of molecular sciences, 2022-05, Vol.23 (11), p.6042

2022

Volltextzugriff (PDF)

A role for RASSF1A in tunneling nanotube formation between cells through GEFH1/Rab11 pathway control

Cell communication and signaling, 2018-10, Vol.16 (1), p.66-20, Article 66

2018

Volltextzugriff (PDF)

Cancer and RASSF1A/RASSF1C, the Two Faces of Janus

Trends in Cancer, 2019-11, Vol.5 (11), p.662-665

2019

Volltextzugriff (PDF)

NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells

Journal of experimental & clinical cancer research, 2019-04, Vol.38 (1), p.158-158, Article 158

2019

Volltextzugriff (PDF)

Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers

Cancers, 2021-11, Vol.13 (23), p.5957

2021

Volltextzugriff (PDF)

Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP

Targeted oncology, 2022-07, Vol.17 (4), p.407-431

2022

Volltextzugriff (PDF)

VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial

Lung cancer (Amsterdam, Netherlands), 2023-08, Vol.182, p.107287, Article 107287

2023

Volltextzugriff (PDF)

A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT‐0701 MAPS phase 3 trial

International journal of cancer, 2022-06, Vol.150 (11), p.1889-1904

2022

Volltextzugriff (PDF)

Investigating Tunneling Nanotubes in Cancer Cells: Guidelines for Structural and Functional Studies through Cell Imaging

BioMed research international, 2020, Vol.2020 (2020), p.1-16

2020

Volltextzugriff (PDF)

Combining sophisticated fast FLIM, confocal microscopy, and STED nanoscopy for live-cell imaging of tunneling nanotubes

Life science alliance, 2024-07, Vol.7 (7), p.e202302398

2024

Volltextzugriff (PDF)

High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway

Molecular cancer therapeutics, 2012-05, Vol.11 (5), p.1203-1213

2012

Volltextzugriff (PDF)

Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial

Cancers, 2019-11, Vol.11 (12), p.1835

2019

Volltextzugriff (PDF)

Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy

European respiratory review, 2013-12, Vol.22 (130), p.565-576

2013

Volltextzugriff (PDF)

Paxillin regulates cell polarization and anterograde vesicle trafficking during cell migration

Molecular biology of the cell, 2017-12, Vol.28 (26), p.3815-3831

2017

Volltextzugriff (PDF)

New Histoprognostic Factors to Consider for the Staging of Colon Cancers: Tumor Deposits, Invasive Tumor Infiltration and High-Grade Budding

International journal of molecular sciences, 2023-02, Vol.24 (4), p.3573

2023

Volltextzugriff (PDF)

RASSF1A, puppeteer of cellular homeostasis, fights tumorigenesis and metastasis - An 1 updated review

Cell death & disease, 2019-12, Vol.10 (12)

2019

Volltextzugriff (PDF)

La kinase Hippo, NDR2, contribue au phénotype migratoire/métastatique des cellules de cancer bronchique non à petites cellules

Morphologie, 2021-09, Vol.105 (350), p.S7-S7

2021

Volltextzugriff (PDF)

Le Réseau Normand d’étude des TNTs : appel à collaboration

Morphologie, 2021-09, Vol.105 (350), p.S14-S15

2021

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(36)
Webseiten
(1)

Sprache

Englisch
(29)
Französisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

RASSF1A, puppeteer of cellular homeostasis, fights tumorigenesis, and metastasis-an updated review

RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non-Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway

Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review)

Optimization of Advanced Live-Cell Imaging through Red/Near-Infrared Dye Labeling and Fluorescence Lifetime-Based Strategies

Centrosome, the Newly Identified Passenger through Tunneling Nanotubes, Increases Binucleation and Proliferation Marker in Receiving Cells

Hypoxia-induced activation of NDR2 underlies brain metastases from Non-Small Cell Lung Cancer

The Use of Pro-Angiogenic and/or Pro-Hypoxic miRNAs as Tools to Monitor Patients with Diffuse Gliomas

A role for RASSF1A in tunneling nanotube formation between cells through GEFH1/Rab11 pathway control

Cancer and RASSF1A/RASSF1C, the Two Faces of Janus

NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells

Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers

Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP

VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial

A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT‐0701 MAPS phase 3 trial

Investigating Tunneling Nanotubes in Cancer Cells: Guidelines for Structural and Functional Studies through Cell Imaging

Combining sophisticated fast FLIM, confocal microscopy, and STED nanoscopy for live-cell imaging of tunneling nanotubes

High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway

Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial

Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy

MSH2/BRCA1 expression as a DNA-repair signature predicting survival in early-stage lung cancer patients from the IFCT-0002 Phase 3 Trial

Paxillin regulates cell polarization and anterograde vesicle trafficking during cell migration

New Histoprognostic Factors to Consider for the Staging of Colon Cancers: Tumor Deposits, Invasive Tumor Infiltration and High-Grade Budding

RASSF1A, puppeteer of cellular homeostasis, fights tumorigenesis and metastasis - An 1 updated review

La kinase Hippo, NDR2, contribue au phénotype migratoire/métastatique des cellules de cancer bronchique non à petites cellules

Le Réseau Normand d’étude des TNTs : appel à collaboration

Suchergebnisse filtern